Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg ''''

Introduction

VOGLIGOLD G3 M0.3 is a potent combination medication formulated for the management of Type 2 Diabetes Mellitus (T2DM). It contains three active pharmaceutical ingredients: Voglibose (0.3 mg), Glimepiride (3 mg), and Metformin Hydrochloride (500 mg). Each component plays a crucial role in regulating blood sugar levels, making this medication an effective solution for patients who require multi-faceted glucose control.

This guide provides a detailed overview of VOGLIGOLD G3 M0.3, including its mechanism of action, benefits, dosage recommendations, potential side effects, and precautions.

Key Ingredients & Their Roles

1. Voglibose (0.3 mg)

• Class: Alpha-glucosidase inhibitor

• Function: Delays carbohydrate absorption in the intestine, preventing postprandial (after-meal) spikes in blood sugar levels.

• Effect: Lowers post-meal glucose levels and improves glycemic control.

2. Glimepiride (3 mg)

• Class: Sulfonylurea

• Function: Stimulates pancreatic beta cells to release insulin, reducing blood glucose levels.

• Effect: Enhances insulin secretion, ensuring better control over fasting and postprandial sugar levels.

3. Metformin Hydrochloride (500 mg)

• Class: Biguanide

• Function: Reduces hepatic glucose production, enhances insulin sensitivity, and improves glucose uptake by muscles.

• Effect: Helps in maintaining stable blood sugar levels throughout the day and minimizes insulin resistance.

Mechanism of Action

VOGLIGOLD G3 M0.3 works by combining the complementary actions of its three active ingredients:

1. Voglibose slows down carbohydrate digestion, preventing rapid spikes in blood sugar levels post meals.

2. Glimepiride increases insulin secretion from the pancreas, helping in better glucose utilization.

3. Metformin reduces liver glucose production and enhances insulin sensitivity, leading to improved overall glycemic control.

This triple-drug therapy ensures comprehensive diabetes management by targeting different pathways of glucose regulation.

Key Benefits

• Effective Blood Sugar Regulation – Targets fasting, postprandial, and overall blood glucose levels.

• Reduces Insulin Resistance – Improves insulin sensitivity, leading to better glucose uptake by cells.

• Prevents Postprandial Hyperglycemia – Voglibose component slows down carbohydrate digestion and absorption.

• Enhances Pancreatic Function – Glimepiride boosts insulin secretion from pancreatic beta cells.

• Minimizes Risk of Hypoglycemia – The combination works in a balanced way to regulate blood sugar without excessive drops.

• Improves Glycemic Variability – Provides better control over fluctuations in blood sugar throughout the day.

Dosage & Administration

• The typical dosage of VOGLIGOLD G3 M0.3 is one tablet per day, preferably taken with meals.

• Doctor’s Consultation: Dosage adjustments may be needed based on individual patient response and glycemic levels.

• Missed Dose: If a dose is missed, take it as soon as remembered. However, if it is close to the next scheduled dose, skip it—do not double dose.

• Overdose Risk: In case of overdose, immediate medical attention is required due to the potential risk of severe hypoglycemia.

Potential Side Effects

While VOGLIGOLD G3 M0.3 is generally well tolerated, some patients may experience side effects, including:

Common Side Effects

• Gastrointestinal Discomfort – Bloating, gas, nausea, or diarrhea (due to Metformin and Voglibose).

• Mild Hypoglycemia – Symptoms like dizziness, sweating, and tremors (due to Glimepiride).

• Weight Changes – Some individuals may experience slight weight gain due to Glimepiride.

Serious Side Effects (Rare Cases)

• Severe Hypoglycemia – If combined with other diabetic medications or improper dosing.

• Lactic Acidosis – A rare but serious condition linked to excessive Metformin accumulation.

• Liver or Kidney Dysfunction – Patients with existing liver or kidney conditions should use this medication cautiously.

Precautions & Warnings

1. Who Should Avoid This Medication?

• Patients with severe kidney or liver disease.

• Those with a history of lactic acidosis.

• Pregnant or breastfeeding women should consult a doctor before use.

• Individuals allergic to Voglibose, Glimepiride, or Metformin.

2. Drug Interactions

• Other Diabetes Medications: Increased risk of hypoglycemia if combined with insulin or other sulfonylureas.

• NSAIDs & Corticosteroids: May alter blood sugar control.

• Alcohol: Increases the risk of lactic acidosis and hypoglycemia.

• Beta-Blockers: May mask the symptoms of hypoglycemia.

3. Dietary & Lifestyle Considerations

• Balanced Diet: Focus on a low-glycemic index diet with fiber-rich foods.

• Regular Exercise: Helps in improving insulin sensitivity.

• Hydration: Stay well-hydrated to minimize Metformin-induced gastrointestinal effects.

Price & Availability in India

The price of VOGLIGOLD G3 M0.3 varies depending on the brand and pharmacy. On average, a strip of 10 tablets may cost between ₹150 – ₹250 in India. The medication is available in retail pharmacies and online platforms with a valid prescription.

FAQs

1. Can VOGLIGOLD G3 M0.3 be taken on an empty stomach?

No, it is best taken with meals to enhance efficacy and reduce gastrointestinal side effects.

2. How long does it take to see the effects?

Patients may notice improved blood sugar levels within a few days to weeks, depending on individual response.

3. Can this medication be used in Type 1 Diabetes?

No, VOGLIGOLD G3 M0.3 is only for Type 2 Diabetes Mellitus patients.

4. Is this medicine safe for elderly patients?

Yes, but dose adjustments may be necessary due to age-related kidney function decline.

5. Can I stop taking VOGLIGOLD G3 M0.3 if my sugar levels normalize?

No, stopping the medication without a doctor’s consultation can lead to uncontrolled diabetes and complications.

Final Thoughts

VOGLIGOLD G3 M0.3 is a highly effective combination therapy for Type 2 Diabetes Mellitus, offering a multi-pronged approach to glycemic control. With the combined action of Voglibose, Glimepiride, and Metformin, this medication provides better glucose management, reduces insulin resistance, and helps maintain overall metabolic health.

However, proper dosage adherence, lifestyle modifications, and regular monitoring are crucial to maximize the benefits while minimizing side effects. Always consult a healthcare professional before starting or altering any diabetes medication regimen.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW